SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-043729
Filing Date
2022-11-30
Accepted
2022-11-30 16:20:56
Documents
13
Period of Report
2022-11-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 8-K brhc10044882_8k.htm   iXBRL 8-K 28882
  Complete submission text file 0001140361-22-043729.txt   204777

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bngo-20221130.xsd EX-101.SCH 4328
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20221130_def.xml EX-101.DEF 17539
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20221130_lab.xml EX-101.LAB 27037
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20221130_pre.xml EX-101.PRE 19724
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10044882_8k_htm.xml XML 6220
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 221435845
SIC: 3826 Laboratory Analytical Instruments